Sentiss Pharma Private Limited, a active private limited company, was established on 13 January 1994 in New Delhi, Delhi, India. Engaging in medical & laboratory equipment within the manufacturing sector, it holds CIN: U74899DL1994PTC056894. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹5.88 Cr.
Formerly known as Promed Exports Private Limited. It upholds a compliant status. Employing 689 professional, Its leadership includes Canakapalli Bhaktavatasala Rao (Director), Deepak Bahri (Managing Director), Mahesh Kumar Garg (Director). Past directors included Arvind Sharma, Canakapalli Bhaktavatasala Rao, Malakeezhu Krishna Gopala Krishna Pillai. It holds ₹273.88 Cr open charges and ₹795.76 Cr settled loans. Its latest AGM occurred on 17 March 2025, with the balance sheet filed on 31 March 2024. It is based at 212 Ashirwad Commercialcomplex D-I Green Park, New Delhi, Delhi, 110016.
U74899DL1994PTC056894
056894
13 January 1994
₹10.00 Cr
₹5.88 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Sentiss Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Canakapalli Bhaktavatasala Rao | Director | 29 Apr 2019 | Current |
| Deepak Bahri | Managing Director | 01 May 1995 | Current |
| Mahesh Kumar Garg | Director | 09 Jun 2015 | Current |
| Geeta Mathur | Director | 17 Jul 2017 | Current |
| Sameer Agarwal | Director | 10 Feb 2025 | Current |
| Deepak Kumar Khungar | Director | 21 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 19 Jul 2019 | Past |
| Pramod Abcsdd | Additional Director | 25 Sep 2019 | Past |
| Pramod Abcsdd | Director | 16 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 17 Sep 2022 | Past |
| Pramod Abcsdd | Director | 15 Jan 2016 | Past |
| Pramod Abcsdd | Director | 09 Nov 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sentiss Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.42% increase. The company also saw a substantial improvement in profitability, with a 102.66% increase in profit. The company's net worth Soared by an impressive increase of 24.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sentiss Pharma had a promoter holding of 99.78% and a public holding of 0.22%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,738,800,000.00
₹7,957,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2025 | Others | ₹20.00 Cr | Open |
| 26 Nov 2024 | Others | ₹54.88 Cr | Open |
| 28 Feb 2024 | Hdfc Bank Limited | ₹30.00 Cr | Open |
| 23 Sep 2023 | Others | ₹50.00 Cr | Open |
| 23 Jan 2020 | Others | ₹34.00 Cr | Open |
Explore comprehensive loan charge details -
Sentiss Pharma has a workforce of 689 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sentiss Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sentiss Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 25 Jul 2024 via Charge ID 100959360 with Canara Bank was fully satisfied on 29 Aug 2025. was recorded as a recent event.
Sentiss Pharma Private Limited last Annual general meeting of members was held on 17 Mar 2025 as per latest MCA records. was recorded as a recent event.
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101076333 was registered on 15 Mar 2025. was recorded as a recent event.
Progress on Sameer Agarwal was appointed as a Director was appointed as a Director on 10 Feb 2025 & has been associated with this company since 9 months 21 days . was documented.
The activity A charge with Others of Rs. 34.00 Cr registered on 23 Jan 2020 with Charge ID 100322555 was modified on 26 Dec 2024. was completed.
Progress on A charge with Others amounted to Rs. 54.88 Cr with Charge ID 101006068 was registered on 26 Nov 2024. was documented.
The CIN of Sentiss Pharma Private Limited is U74899DL1994PTC056894.
Sentiss Pharma Private Limited is headquartered at 212 Ashirwad Commercialcomplex D-I Green Park, New Delhi, Delhi, 110016.
Sentiss Pharma Private Limited was incorporated on 13 January 1994.
The current directors of Sentiss Pharma Private Limited are
The primary industry of Sentiss Pharma Private Limited is Manufacturing.
Sentiss Pharma Private Limited is unlisted.
The authorized capital of Sentiss Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹5.88 Cr.
The compliance status of Sentiss Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX